Publications by authors named "S Aizner"
Article Synopsis
- The study examines how age affects liver transplantation outcomes in Israeli patients since age restrictions were lifted in 2014, focusing on patients 18 years and older.
- It analyzed data from 269 transplantations, finding that despite varying one-year survival rates across different age groups, age alone did not significantly impact overall survival outcomes.
- Key health issues like cardiovascular diseases and other pre-existing conditions were identified as crucial factors affecting survival, emphasizing that older, healthy patients should not be automatically denied access to transplantation.
Background: Desensitization protocols have been developed in order to overcome the immunological barrier of donor-specific anti-HLA antibodies (DSA).
Methods: During 2006-2012, we implemented a program for desensitizing sensitized (positive DSA, negative NIH-CDC crossmatch) living-donor recipients. The long-term outcome of 36 sensitized recipients, treated with IVIG and plasmapheresis (PP), with or without rituximab (added when > 7500 MFI), was compared to 252 non-sensitized living-donor recipients.
Biliary complications after liver transplantation remain a serious cause of morbidity and mortality. Direct invasive cholangiographic techniques, endoscopic retrograde cholangiography (ERCP) or percutaneous transhepatic cholangiography (PTC), have procedure-related complications. Magnetic resonance cholangiopancreatography (MRCP) is non-invasive, safe, and accurate.
View Article and Find Full Text PDFBackground: Preexisting spontaneous portosystemic shunts increase the risk of posttransplantation portal vein thrombosis. Portosystemic shunts may also be placed surgically to manage posttransplant portal vein stenosis/thrombosis. Both types may be complicated by hepatic encephalopathy.
View Article and Find Full Text PDF